Immunization News and Research

RSS

Are we failing to bridge the gap in HPV vaccine coverage globally?

Study reveals stark global inequities in HPV vaccine coverage across 84 countries, finding that nations with the highest burden of cervical cancer often have the lowest vaccination rates. However, new WHO recommendations and an increase in vaccine supply may help narrow this gap and improve equitable access.

29 Aug 2023

Keck Medicine of USC experts highlight the importance of COVID-19, flu and RSV vaccines

Over the last few years, the nation has been through multiple rounds of COVID-19 vaccinations. This fall, the COVID-19 vaccine will be offered annually.

25 Aug 2023

Novavax's protein-based COVID vaccine induces broad functional immune response against XBB subvariants, data shows

Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that its updated protein-based XBB COVID vaccine candidate induced neutralizing antibody responses to the EG.5.1 and XBB.1.16.6 subvariants in small animal and non-human primate studies.

25 Aug 2023

Timing and cost of new vaccines vary by virus and health insurance status

As summer edges toward fall, thoughts turn to, well, vaccines.

24 Aug 2023

Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery

In this interview, News-Medical had the opportunity to speak with Dr. Xiaobing Han, Principal Scientist for Antibody Discovery at Rapid Novor.

From Rapid Novor Inc 23 Aug 2023

Malaria vaccine and drug combination reduces hospitalizations, deaths in children

The final results of a landmark study published in The Lancet Infectious Diseases confirm that the benefits of combining the RTS,S/AS01E (RTS,S) malaria vaccine with antimalarial drugs in settings of highly seasonal malaria transmission continue over five years.

22 Aug 2023

Moffitt receives NCI grant to investigate virus-associated tumors among HIV patients in sub-Saharan Africa

The Center for Immunization and Infection Research in Cancer at Moffitt Cancer Center is expanding its viral infection research in Africa. The cancer center has received a $5.5 million, five-year specialized research center grant (U54CA277834) from the National Cancer Institute to investigate virus-associated tumors that disproportionately impact men and women living with HIV in sub-Saharan Africa.

17 Aug 2023

Study suggests antibodies triggered by COVID-19 mRNA vaccination may depend on prior infection history

Researchers evaluated distinct immune responses to mRNA and vector-based COVID-19 vaccines and natural SARS-CoV-2 infections.

17 Aug 2023

Most infants admitted to ICU for RSV were previously healthy, study finds

Most infants admitted to the intensive care or high acuity unit for respiratory syncytial virus (RSV) infections during fall 2022 were previously healthy and born at term, according to a new study reported in JAMA Network Open.

16 Aug 2023

Human challenge trials: A game-changer in vaccine development? Examining their role in shaping the pandemic response

The history of using human challenge trials in developing vaccines.

15 Aug 2023

Investigating the potential differences in waning of post-vaccination neutralizing antibody titers

The decline patterns of neutralizing antibodies following coronavirus disease 2019 (COVID-19) vaccination.

15 Aug 2023

UAB researchers identify cell-surface marker that indicates fate of T cells

Follicular helper T cells, or Tfh cells, have a crucial role in immune defense. Without Tfh cells, B cells cannot form germinal center, or GC, responses during which high-affinity antibodies are generated.

14 Aug 2023

The protective effect of previous infections and vaccinations on SARS-CoV-2 Omicron infection

Researchers estimate the protective effect of hybrid immunity on infection with the SARS-CoV-2 Omicron variant.

14 Aug 2023

Novel multi-epitope subunit vaccine induces robust immune response against Epstein-Barr virus

Scientists have developed a lymph node-targeted multi-epitope subunit vaccine that induces strong humoral and cellular immune responses against EBV in mice.

14 Aug 2023

Does convalescent serum treatment lower mortality in SARS-CoV-2-infected individuals?

Researchers evaluated the impact of convalescent serum therapy on all-cause mortality among COVID-19 patients.

14 Aug 2023

Moderna vaccine linked to lower risk of adverse events in older adults

While mRNA vaccines against COVID-19 have been found to be safe and effective for the general population, in-depth evidence about safety and effectiveness for older adults and individuals with chronic health conditions is more limited.

2 Aug 2023

Can vitamin D have positive effects on reducing cortical pathology, oxidative stress, and neurofilament light chain serum levels?

Researchers use an established murine model of cortical inflammatory demyelination to investigate the effects of vitamin D.

2 Aug 2023

Intranasally administered SARS-CoV-2 RBD-based nanoparticle vaccine provides protection against lung pathology and viral load

In a recent study, researchers working at Ohio State University in the United States of America (USA) developed an intranasal subunit vaccine.

2 Aug 2023

RSV vaccines for older adults: 2023 ACIP recommendations

A recent report published in Morbidity and Mortality Weekly Report provided clinical guidance on Respiratory syncytial virus (RSV) vaccines for adults ≥60 years.

1 Aug 2023

The incidence of diabetes following mRNA, inactivated COVID-19 vaccines, and after SARS-CoV-2 infection

Researchers evaluate the risk of new-onset diabetes linked with COVID-19 vaccination and infection.

31 Jul 2023

Immunization News and Research

Are we failing to bridge the gap in HPV vaccine coverage globally?

Keck Medicine of USC experts highlight the importance of COVID-19, flu and RSV vaccines

Novavax's protein-based COVID vaccine induces broad functional immune response against XBB subvariants, data shows

Timing and cost of new vaccines vary by virus and health insurance status

Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery

Malaria vaccine and drug combination reduces hospitalizations, deaths in children

Moffitt receives NCI grant to investigate virus-associated tumors among HIV patients in sub-Saharan Africa

Study suggests antibodies triggered by COVID-19 mRNA vaccination may depend on prior infection history

Most infants admitted to ICU for RSV were previously healthy, study finds

Human challenge trials: A game-changer in vaccine development? Examining their role in shaping the pandemic response

Investigating the potential differences in waning of post-vaccination neutralizing antibody titers

UAB researchers identify cell-surface marker that indicates fate of T cells

The protective effect of previous infections and vaccinations on SARS-CoV-2 Omicron infection

Novel multi-epitope subunit vaccine induces robust immune response against Epstein-Barr virus

Does convalescent serum treatment lower mortality in SARS-CoV-2-infected individuals?

Moderna vaccine linked to lower risk of adverse events in older adults

Can vitamin D have positive effects on reducing cortical pathology, oxidative stress, and neurofilament light chain serum levels?

Intranasally administered SARS-CoV-2 RBD-based nanoparticle vaccine provides protection against lung pathology and viral load

RSV vaccines for older adults: 2023 ACIP recommendations

The incidence of diabetes following mRNA, inactivated COVID-19 vaccines, and after SARS-CoV-2 infection

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News